You don’t expect a quiet electrical pulse, buried deep inside the brain, to offer the kind of lift that years of failed antidepressants couldn’t touch. Yet for a group of patients in Shanghai, people who had run out of options long before researchers enrolled them, a thin implanted wire has begun to move the needle on lives that felt locked in place.
In an open label trial led by teams at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, the University of Cambridge, and Fudan University, deep brain stimulation delivered to two small regions involved in stress and reward improved severe, treatment resistant depression and anxiety in half of the 26 participants. The study, published in Nature Communications, did something even rarer. It uncovered a biological signature, a slow rhythm in the bed nucleus of the stria terminalis called theta activity, that predicted who would benefit and who would not.
When Symptoms Shift, Lives Shift With Them
The patients arrived with years of failed treatments behind them. Many had endured long episodes of major depression despite medication after medication. Some had already tried electroconvulsive therapy or psychotherapy with little effect. Neurosurgeons implanted electrodes capable of stimulating both the bed nucleus of the stria terminalis, which shapes prolonged fear and anxiety, and the nucleus accumbens, which anchors motivation and reward.
The months that followed carried a kind of slow turning. Thirteen of the 26 patients experienced a clinically significant reduction in depression scores. Nine, about 35 percent of the group, reached remission. Anxiety scores fell as well. Disability ratings eased. Quality of life, measured by gold standard instruments, ticked upward in ways that the researchers describe as steady rather than dramatic, the way light appears gradually when a curtain is pulled back.
“Deep brain stimulation shows real promise at tackling treatment-resistant depression, which can have a huge impact on peoples lives. But our study hasnt just highlighted this promise, its given us a potential and much-needed objective marker to say which patients will respond best.”
Valerie Voon
What made the results feel different was not only the clinical effect but the imprint it carried in the brain. When patients were briefly connected to external recording equipment shortly after surgery, the electrodes captured slow oscillations in the BNST. Higher theta activity aligned with more severe depression and anxiety. Lower theta at baseline predicted the patients who would later show the clearest improvement.
That signal was not confined to a single moment. It held steady across different recording conditions, whether patients kept their eyes open or closed. It showed up again in the connection patterns between the BNST and the prefrontal cortex, where stronger coherence in the theta band predicted worse outcomes. And it appeared in a wireless stream of intracranial recordings during the randomized crossover phase of the trial. When stimulation was active, BNST theta dropped. When patients reported feeling more anxious, theta rose again.
The Circuit Reveals Something About The Person
The researchers were not interested only in the brain. Before treatment, they asked patients to rate how they felt when viewing images that were pleasant, neutral, or negative. A pattern emerged. Patients who reacted most strongly to negative images at baseline were the least likely to benefit from the stimulation that followed. Those with a gentler negative bias fared better. Their brains also carried the theta profile linked to later improvement.
That simple psychological measure sat in meaningful conversation with the neural recordings. In fact, BNST theta appeared to mediate the relationship between negative emotional bias and symptom improvement. The circuit behaved like a hinge that swung open most easily for those whose emotional responses left room for the stimulation to work.
Day to day, the physiology proved even more revealing. During the blinded crossover portion of the study, the implanted devices streamed short sessions of neural activity while patients rated their mood and anxiety in real time. Theta power rose with anxiety but not mood. The distinction underscored how depression and anxiety, though entwined, can diverge across the minutes that structure a day. The signal tracked anxiety with a fidelity that encourages the development of closed loop stimulation. High theta could become a cue to turn the stimulation up. Low theta could call for dialing it back.
A Targeted Therapy For A Disorder With Many Faces
Even as the results carry practical promise, they carry an intellectual one too. Depression is not a single disorder. It is a mosaic of phenotypes, some anxious, some marked by anhedonia, some dominated by cognitive slowing or agitation. In this trial, anhedonia did not track neatly with the improvements in mood or anxiety. It resisted, or at least moved differently.
That divergence suggests that stimulation of the BNST and nucleus accumbens may benefit a particular biotype, one defined by anxiety, anticipatory threat, and negative bias. The physiological signature sits within this emotional territory. It draws a line around a population whose circuitry appears responsive to the intervention.
Precision is rarely a word associated with psychiatry, a field better known for symptom clusters than neural maps. Yet here the map is literal. The tractography shows pathways from the BNST into the dorsal anterior cingulate and lateral frontal cortex, regions long implicated in emotional regulation and internal conflict. The theta signal bridges psychology and physiology. The clinical improvement closes the loop.
There are limits. The sample is small. Some crossover effects lasted longer than intended. Certain findings did not survive correction for multiple comparisons. The randomized trial results are still forthcoming. Yet the arc of the study is unmistakable. It moves from subjective distress to measurable signal, from signal to targeted stimulation, from stimulation to relief.
For people living in the narrow margins carved out by refractory depression, this work offers something more than a technical proof. It offers a sense that the illness is not a permanent fog but a pattern in a circuit, one that can be nudged with care, precision, and electricity until the person beneath it begins to reappear.
Journal: Nature Communications
Article: Prefrontal bed nucleus of the stria terminalis physiological and neuropsychological biomarkers predict therapeutic outcomes in depression
URL: https://www.nature.com/articles/s41467-025-65179-z
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.